{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:46:52Z","timestamp":1789181212859,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00198-017-3906-6","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T11:55:34Z","timestamp":1484567734000},"page":"767-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates"],"prefix":"10.1007","volume":"28","author":[{"name":"Adherence Working Group of the International Osteoporosis Foundation and the European Calcified Tissue Society","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Diez-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Agnusdei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. F.","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. T.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gua\u00f1abens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hadji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hiligsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Josse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Obermayer-Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Prieto-Alhambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Eastell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"issue":"8","key":"3906_CR1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","volume":"18","author":"JA Cramer","year":"2007","unstructured":"Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18(8):1023\u20131031","journal-title":"Osteoporos Int"},{"issue":"12","key":"3906_CR2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0025-6196(11)61093-8","volume":"82","author":"P Kothawala","year":"2007","unstructured":"Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ (2007) Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 82(12):1493\u20131501","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"3906_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00198-011-1796-6","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Reginster JY, Kaufman JM, Ringe JD, Adachi JD, Hiligsmann M et al (2012) A reappraisal of generic bisphosphonates in osteoporosis. Osteoporos Int 23(1):213\u2013221","journal-title":"Osteoporos Int"},{"issue":"3","key":"3906_CR4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00223-009-9329-4","volume":"86","author":"M Hiligsmann","year":"2010","unstructured":"Hiligsmann M, Rabenda V, Gathon HJ, Ethgen O, Reginster JY (2010) Potential clinical and economic impact of nonadherence with osteoporosis medications. Calcif Tissue Int 86(3):202\u2013210","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"3906_CR5","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1007\/s00198-013-2364-z","volume":"24","author":"M Hiligsmann","year":"2013","unstructured":"Hiligsmann M, Salas M, Hughes DA, Manias E, Gwadry-Sridhar FH, Linck P et al (2013) Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporos Int 24(12):2907\u20132918","journal-title":"Osteoporos Int"},{"issue":"10","key":"3906_CR6","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00198-011-1668-0","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Cooper C, Hiligsmann M, Rabenda V, Reginster JY, Rizzoli R (2011) Partial adherence: a new perspective on health economic assessment in osteoporosis. Osteoporos Int 22(10):2565\u20132573","journal-title":"Osteoporos Int"},{"issue":"1","key":"3906_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY et al (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23\u201357","journal-title":"Osteoporos Int"},{"issue":"2","key":"3906_CR8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22(2):391\u2013420","journal-title":"Osteoporos Int"},{"issue":"12","key":"3906_CR9","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","volume":"23","author":"A Diez-Perez","year":"2012","unstructured":"Diez-Perez A, Adachi JD, Agnusdei D, Bilezikian JP, Compston JE, Cummings SR et al (2012) Treatment failure in osteoporosis. Osteoporos Int 23(12):2769\u20132774","journal-title":"Osteoporos Int"},{"issue":"4","key":"3906_CR10","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2006-1526","volume":"92","author":"PD Delmas","year":"2007","unstructured":"Delmas PD, Vrijens B, Eastell R, Roux C, Pols HA, Ringe JD et al (2007) Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 92(4):1296\u20131304","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3906_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00198-015-3145-7","volume":"27","author":"KE Naylor","year":"2016","unstructured":"Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV et al (2016) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int 27(1):21\u201331","journal-title":"Osteoporos Int"},{"issue":"6","key":"3906_CR12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00223-015-0040-3","volume":"97","author":"C Carbonell-Abella","year":"2015","unstructured":"Carbonell-Abella C, Pages-Castella A, Javaid MK, Nogues X, Farmer AJ, Cooper C et al (2015) Early (1-year) discontinuation of different anti-osteoporosis medications compared: a population-based cohort study. Calcif Tissue Int 97(6):535\u2013541","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"3906_CR13","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s00198-014-2817-z","volume":"25","author":"MA Paggiosi","year":"2014","unstructured":"Paggiosi MA, Peel N, McCloskey E, Walsh JS, Eastell R (2014) Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study. Osteoporos Int 25(12):2729\u20132741","journal-title":"Osteoporos Int"},{"issue":"1","key":"3906_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1258\/jms.2008.008got","volume":"15","author":"NJ Wald","year":"2008","unstructured":"Wald NJ (2008) Guidance on terminology. J Med Screen 15(1):50","journal-title":"J Med Screen"},{"issue":"12","key":"3906_CR15","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1210\/jc.2015-2957","volume":"100","author":"P Chavassieux","year":"2015","unstructured":"Chavassieux P, Portero-Muzy N, Roux JP, Garnero P, Chapurlat R (2015) Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women? J Clin Endocrinol Metab 100(12):4662\u20134668","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3906_CR16","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jbmr.373","volume":"26","author":"MK Mayranpaa","year":"2011","unstructured":"Mayranpaa MK, Tamminen IS, Kroger H, Makitie O (2011) Bone biopsy findings and correlation with clinical, radiological, and biochemical parameters in children with fractures. J Bone Miner Res 26(8):1748\u20131758","journal-title":"J Bone Miner Res"},{"issue":"10","key":"3906_CR17","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/jbmr.149","volume":"25","author":"IR Reid","year":"2010","unstructured":"Reid IR, Miller PD, Brown JP, Kendler DL, Fahrleitner-Pammer A, Valter I et al (2010) Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies. J Bone Miner Res 25(10):2256\u20132265","journal-title":"J Bone Miner Res"},{"issue":"7","key":"3906_CR18","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2003-1703","volume":"90","author":"H Dobnig","year":"2005","unstructured":"Dobnig H, Sipos A, Jiang Y, Fahrleitner-Pammer A, Ste-Marie LG, Gallagher JC et al (2005) Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab 90(7):3970\u20133977","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"3906_CR19","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1185\/030079904X16768","volume":"20","author":"AI Sebba","year":"2004","unstructured":"Sebba AI, Bonnick SL, Kagan R, Thompson DE, Skalky CS, Chen E et al (2004) Response to therapy with once-weekly alendronate 70\u00a0mg compared to once-weekly risedronate 35\u00a0mg in the treatment of postmenopausal osteoporosis. Curr Med Res Opin 20(12):2031\u20132041","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"3906_CR20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jbmr.1496","volume":"27","author":"A Diez-Perez","year":"2012","unstructured":"Diez-Perez A, Olmos JM, Nogues X, Sosa M, Diaz-Curiel M, Perez-Castrillon JL et al (2012) Risk factors for prediction of inadequate response to antiresorptives. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 27(4):817\u2013824","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"4","key":"3906_CR21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/PL00004183","volume":"11","author":"E Fink","year":"2000","unstructured":"Fink E, Cormier C, Steinmetz P, Kindermans C, Le Bouc Y, Souberbielle JC (2000) Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Osteoporos Int 11(4):295\u2013303","journal-title":"Osteoporos Int"},{"issue":"7","key":"3906_CR22","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","volume":"13","author":"R Hannon","year":"1998","unstructured":"Hannon R, Blumsohn A, Naylor K, Eastell R (1998) Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res 13(7):1124\u20131133","journal-title":"J Bone Miner Res"},{"issue":"6","key":"3906_CR23","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bone.2009.07.089","volume":"45","author":"A Rogers","year":"2009","unstructured":"Rogers A, Glover SJ, Eastell R (2009) A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy. Bone 45(6):1044\u20131052","journal-title":"Bone"},{"issue":"12","key":"3906_CR24","doi-asserted-by":"crossref","first-page":"e80633","DOI":"10.1371\/journal.pone.0080633","volume":"8","author":"R Horne","year":"2013","unstructured":"Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V (2013) Understanding patients\u2019 adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One 8(12):e80633","journal-title":"PLoS One"},{"issue":"7","key":"3906_CR25","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/jbmr.342","volume":"26","author":"R Eastell","year":"2011","unstructured":"Eastell R, Vrijens B, Cahall DL, Ringe JD, Garnero P, Watts NB (2011) Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence. J Bone Miner Res 26(7):1662\u20131669","journal-title":"J Bone Miner Res"},{"issue":"4","key":"3906_CR26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","volume":"47","author":"P Garnero","year":"2001","unstructured":"Garnero P, Borel O, Delmas PD (2001) Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 47(4):694\u2013702","journal-title":"Clin Chem"},{"issue":"1","key":"3906_CR27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1373\/clinchem.2007.094953","volume":"54","author":"P Garnero","year":"2008","unstructured":"Garnero P, Vergnaud P, Hoyle N (2008) Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 54(1):188\u2013196","journal-title":"Clin Chem"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-3906-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-3906-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-3906-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T22:06:15Z","timestamp":1601330775000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-3906-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3906"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-3906-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]}}}